Monteris Medical

Executive Summary

Monteris Medical is a privately held medical device company specializing in laser interstitial thermal therapy (LITT) for minimally invasive neurosurgery. Founded in 1999 and headquartered in Minneapolis, the company is best known for its NeuroBlate® system, which uses real-time MRI guidance to precisely target and ablate brain lesions such as tumors and epileptic foci. Monteris differentiates itself by generating robust prospective, multi-center clinical evidence to support adoption by neurosurgeons and referring physicians. With a focus on evidence-based medicine, the company aims to become the standard of care for LITT procedures. Despite being in a competitive landscape that includes Medtronic’s Visualase system, Monteris’s commitment to clinical data and its established user base position it for potential growth as minimally invasive techniques gain traction in neurosurgery. The company’s pipeline includes expanding indications into epilepsy and pediatric populations, which could significantly broaden its addressable market.

Upcoming Catalysts (preview)

• Q4 2026FDA approval for expanded indication in pediatric brain tumors60% success
• Q2 2026Completion of enrollment in pivotal trial for laser ablation in epilepsy90% success
• Q3 2026Strategic partnership with a major medical device company for global distribution50% success